Biomerica (BMRA) Change in Receivables (2010 - 2026)
Biomerica (BMRA) reported Change in Receivables of -$64000.0 for Q1 2026, down 6.67% on a YoY basis from -$68571.4 in Q1 2025, and up 71.81% sequentially from -$227000.0 in Q4 2025.
Biomerica (BMRA) Change in Receivables (2010 - 2026) Analysis & Trends
Biomerica (BMRA) has 17 years of Change in Receivables data on file, last reported at -$64000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 6.67% year-over-year to -$64000.0; the trailing twelve-month figure through Feb 2026 stood at -$315000.0 (down 325.0% YoY), and the FY2025 full-year result was -$209000.0, down 197.21% from the prior year.
- Change in Receivables improved to -$64000.0 in Q1 2026, from -$227000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $708000.0 in Q3 2023 to a low of -$536000.0 in Q2 2025.
- A 5-year average of $79850.0 and a median of $26015.0 in 2022 frame the typical range for Change in Receivables.
- Peak annual rise in Change in Receivables reached 1687.43% in 2023, while the deepest fall reached 749.12% in 2023.
- Tracing BMRA's Change in Receivables over 5 years: stood at $57000.0 in 2022, then slumped by 749.12% to -$370000.0 in 2023, then soared by 38.11% to -$229000.0 in 2024, then grew by 0.87% to -$227000.0 in 2025, then soared by 71.81% to -$64000.0 in 2026.
- Business Quant data shows BMRA's Change in Receivables at -$64000.0 in Q1 2026, -$227000.0 in Q4 2025, and $512000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | -64,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -64,000.00 |
| Feb 28, 2026 | -64,000.00 |
| Nov 30, 2025 | -227,000.00 |
| Nov 30, 2025 | -227,000.00 |
| Aug 31, 2025 | 512,000.00 |
| Aug 31, 2025 | 512,000.00 |
| May 31, 2025 | -536,000.00 |
| May 31, 2025 | -536,000.00 |
| Feb 28, 2025 | -60,000.00 |
| Feb 28, 2025 | -60,000.00 |
| Nov 30, 2024 | -229,000.00 |
| Nov 30, 2024 | -229,000.00 |
| Aug 31, 2024 | 616,000.00 |
| Aug 31, 2024 | 616,000.00 |
| May 31, 2024 | -187,000.00 |
| May 31, 2024 | -187,000.00 |
| Feb 29, 2024 | 64,000.00 |
| Feb 29, 2024 | 64,000.00 |
| Nov 30, 2023 | -370,000.00 |
| Nov 30, 2023 | -370,000.00 |